PRAX today
$346.21+$8.62 (+2.55%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourDescending Triangle
1 hourLeaning Bearish
15 minBearish
5 minAscending Triangle
Daily trend turns up above $392.70
Key levels
Resistance$392.70
Resistance$365.71
Support$333.46
Support$314.14
Latest news & SEC filings
AnalystRBC Capital keeps Outperform on Praxis Precision Medicine, lifts target to $478
AnalystWedbush keeps Underperform on Praxis Precision Medicine, lifts target to $189
AnalystWells Fargo trims Praxis Precision Medicine target to $343, keeps neutral stance
All PRAX news →About Praxis Precision Medicines
Praxis Precision Medicines is a clinical-stage biopharmaceutical company developing treatments for central nervous system disorders. It operates two discovery platforms: Cerebrum, for oral small molecule therapies, and Solidus, for antisense oligonucleotides. Its pipeline targets epilepsy and movement disorders, including essential tremor and developmental and epileptic encephalopathies. The company is based in the United States and develops therapies for patients with these neurological conditions.
Based on the company's 10-K filed Feb 19, 2026.
Nasdaq · Healthcare
Praxis Precision Medicines, Inc. (PRAX)
What Is the Price Target for PRAX?
SEPT Low Target
$162.00
SEPT Mid Target
$582.00
SEPT High Target
$1201.00
Analyst Consensus
$582.00
Is PRAX a Buy or Sell Right Now?
Thesis
- •Revenue growing 249.5% YoY with UNKNOWN trend — consistent growth.
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PRAX.
Start Free Trial →Is PRAX Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B, Analyst Consensus
Fair Value
$464.78
12
Moat Score
NONE
3/9
Piotroski Score
60.6
Altman Z-Score
What Is Smart Money Doing with PRAX?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
BUYING
2 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Arbuckle Stuart A | director | Buy | 1,371 | - | Jun 10, 2026 |
| Chodakewitz Jeffrey | director | Buy | 1,371 | - | Jun 10, 2026 |
| YOUNG WILLIAM D | director | Buy | 1,371 | - | Jun 10, 2026 |
| DeSimone Jill | director | Buy | 1,371 | - | Jun 10, 2026 |
| Cudkowicz Merit Ester | director | Buy | 1,371 | - | Jun 10, 2026 |
| MITCHELL DEAN J | director | Buy | 1,371 | - | Jun 10, 2026 |
| KINDLER JEFFREY B | director | Buy | 1,371 | - | Jun 10, 2026 |
| Norden Gregory | director | Buy | 1,371 | - | Jun 10, 2026 |
| Nemiroff Alex | officer | Buy | 78 | $13K | May 14, 2026 |
| Mastrocola Lauren | officer | Buy | 127 | $21K | May 14, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PRAX Growth Story
Revenue YoY
249.5%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-32.03%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for PRAX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PRAX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:25:52 | $346.21 | 40,840 | $$14.1M | BUY |
| 20:29:05 | $346.78 | 1,060 | $$368K | SELL |
| 20:27:57 | $347.79 | 2,000 | $$696K | BUY |
| 20:04:09 | $348.36 | 1,340 | $$467K | MIDPOINT |
| 20:03:55 | $348.36 | 2,425 | $$845K | MIDPOINT |
5 dark pool trades shown · $$16.5M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for PRAX
PREVIEWSEPT Investing provides real-time options flow tracking for PRAX, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $380 | Nov 20 | 9 | $$1560 | 2 | SWEEP |
| CALL | $380 | Dec 18 | 37 | $$6160 | 2 | SWEEP |
| CALL | $380 | Dec 18 | 37 | $$3080 | 1 | SWEEP |
| CALL | $380 | Nov 20 | 9 | $$780 | 1 | SWEEP |
| CALL | $380 | Dec 18 | 37 | $$15.4K | 5 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Praxis Precision Medicines, Inc. (PRAX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (5 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PRAX — frequently asked questions
What is PRAX stock price today?
Praxis Precision Medicines, Inc. (PRAX) is at $346.21, up 2.55% (+$8.62) at the Nov 11, 2026 close.
Why is PRAX stock moving today?
Latest PRAX news — Nov 10, 2026: RBC Capital keeps Outperform on Praxis Precision Medicine, lifts target to $478 · Nov 10, 2026: Wedbush keeps Underperform on Praxis Precision Medicine, lifts target to $189
Why did PRAX stock move on Nov 9, 2026?
Praxis Precision Medicines shares surged 16.83% today, closing at $332.97 on volume of over 1 million shares. The rally coincided with the company's Q3 2026 earnings release and business update, along with an 8-K filing disclosing a major company event.
What is the PRAX price target?
The average analyst price target for PRAX is $582.00, ranging from $162 to $1201, based on 13 analysts.
What do analysts rate PRAX?
Analyst ratings for PRAX: 19 Buy, 1 Hold, 1 Sell — consensus Strong Buy.
Did PRAX beat earnings?
PRAX last reported on Nov 9, 2026: EPS -$3.23 vs -$3.66 expected — a beat of 11.7%.
Does PRAX pay a dividend?
PRAX does not currently pay a dividend.
What are PRAX support and resistance levels?
Support: $333.46, $314.14, $294.95. Resistance: $365.71, $392.70.
What are insiders doing with PRAX?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on PRAX?
Nov 10, 2026: RBC Capital keeps Outperform on Praxis Precision Medicine, lifts target to $478 · Nov 10, 2026: Wedbush keeps Underperform on Praxis Precision Medicine, lifts target to $189 · Nov 10, 2026: Wells Fargo trims Praxis Precision Medicine target to $343, keeps neutral stance